Farther Finance Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Buy
11,387
+2,008
+21% +$251K 0.01% 783
2025
Q4
$1.14M Buy
9,379
+1,849
+25% +$212K 0.01% 819
2025
Q3
$755K Buy
7,530
+448
+6% +$40.4K 0.01% 867
2025
Q2
$587K Buy
7,082
+6,032
+574% +$481K 0.01% 835
2025
Q1
$82.1K Buy
1,050
+40
+4% +$3.58K ﹤0.01% 1642
2024
Q4
$91K Buy
1,010
+10
+1% +$969 ﹤0.01% 1345
2024
Q3
$98.8K Sell
1,000
-43
-4% -$4.22K ﹤0.01% 1309
2024
Q2
$97K Buy
1,043
+43
+4% +$3.85K ﹤0.01% 1144
2024
Q1
$93.8K Buy
1,000
+500
+100% +$46.4K 0.01% 965
2023
Q4
$44.6K Sell
500
-130
-21% -$9.65K ﹤0.01% 1076
2023
Q3
$46K Hold
630
0.01% 798
2023
Q2
$52.4K Buy
630
+130
+26% +$10.9K 0.01% 653
2023
Q1
$38.1K Buy
500
+470
+1,567% +$39K 0.01% 690
2022
Q4
$2.49K Buy
+30
New +$2.43K ﹤0.01% 1380

Other funds holding XBI